Thursday in Cleveland, government officials came together to announce how they are combating the cost of medications through the Inflation Reduction Act.
CLEVELAND — The price of prescription drugs has long been a source of frustration for the people who depend on them. Thursday in Cleveland, government officials came together to announce how they are combating the cost through the Inflation Reduction Act.
"They're charging me $200 or $300. I don't have that. So when that medication comes up, and that's the price, I can't afford it. I leave it sitting there," said Penland."I shouldn't have to take a pill because it cost so much that I need to break it in half," said Penland. "Whether it was here or when I was working for another company where patients would have to sacrifice their health because the copay was way too high," said Amer Najjar, owner of Broadway Pharmacy.Some provisions have already gone into effect, while others are still to come. As for Penland, she wants her health to come before the dollar signs.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Stellantis Resumes Construction On EV Battery Plant In CanadaStellantis and LGES reached a new agreement with the Canadian government, which has pledged 'to level the playing field' with the U.S. Inflation Reduction Act.
Read more »
New Bill Would Require Medicare to Cover 'Home Resiliency' Amid Worsening Climate Crisis“Climate justice is a matter of disability justice,' said Sen. Ed Markey. 'It's time that we guarantee that seniors and people with disabilities can safely weather the climate crisis.'
Read more »
Op-ed: Medicare agency limiting access to Alzheimer’s treatmentCommentary: A new treatment for Alzheimer’s disease, lecanemab, will likely receive traditional FDA approval on Thursday. Unfortunately, the Centers for Medicare & Medicaid Services is closing the door to ready access to this new treatment.
Read more »
Patients, doctors share Medicare Advantage experiences ahead of deadline for NYC retireesTens of thousands of retired New York City workers and their dependents must soon decide whether to opt out of a new privatized Medicare plan that’s slated to replace their existing coverage — a fate that some retirees are dreading.
Read more »
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverageLeqembi slowed cognitive decline in a clinical trial, but the treatment is expensive and carries serious risks of brain swelling and bleeding.
Read more »